Scarica l'app Stockscreener
33.21
0.21%
0.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché APLS Giù?
Forum
Previsione
Apellis Pharmaceuticals Inc Azioni (APLS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
17.73%
172.32
|
146.38 | 110.40 | 94.97 | 44.85 |
Operating Expenses
|
1.52%
234.41
|
230.90 | 247.48 | 215.41 | 219.93 |
| Benefits Costs and Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
| Costs And Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
| Operating Income/Loss |
26.54%
-62.09
|
-84.52 | -137.08 | -120.44 | -175.08 |
| Income/Loss From Continuing Operations Before Tax |
23.98%
-66.25
|
-87.15 | -140.00 | -121.84 | -177.50 |
| Income Tax Expense/Benefit |
88.05%
0.17
|
1.423 | 0.233 | 0.194 | 0.282 |
| Income/Loss From Continuing Operations After Tax |
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
|
Net Income/Loss
|
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
| Diluted Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
| Basic Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
| Diluted Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):